News

Novartis CEO: Tariffs are an overhang on the pharmaceutical sector
CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year.
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
Tariffs are an overhang on pharma sector, but we will comeback, says Novartis CEO Vas Narasimhan
Vas Narasimhan, Novartis CEO, joins 'Money Movers' to discuss tariffs on pharmaceuticals, second quarter earnings and outlook ...
Swedish Drugmaker Sobi Doesn’t See Pharma Tariffs as ‘Imminent’
Drugmaker Swedish Orphan Biovitrum AB’s Chief Executive Officer Guido Oelkers said he doesn’t think tariff threats on the ...
STAT4d
Pharmalittle: We’re reading about Trump and pharma tariffs, an abortion pill ruling, and more
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...